XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,844,503 | -52.0% | 53,996 | -45.9% | 0.56% | -52.9% |
| Q2 2023 | $3,840,606 | +11.0% | 99,756 | +3.2% | 1.19% | -16.8% |
| Q1 2023 | $3,458,853 | -65.4% | 96,643 | -61.9% | 1.43% | -50.1% |
| Q4 2022 | $10,001,617 | +12.6% | 253,655 | +3.1% | 2.86% | -4.8% |
| Q3 2022 | $8,880,000 | +25.5% | 245,992 | +5.7% | 3.00% | +37.9% |
| Q2 2022 | $7,077,000 | +395.6% | 232,630 | +130.1% | 2.18% | +268.7% |
| Q1 2022 | $1,428,000 | -54.3% | 101,081 | +1.1% | 0.59% | -53.3% |
| Q4 2021 | $3,124,000 | +951.9% | 100,000 | +414.6% | 1.27% | +653.6% |
| Q3 2021 | $297,000 | – | 19,432 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |